Boehringer Ingelheim Ingelvac PRRS MLV Swine Vaccine 500 mL/250 Dose

Boehringer Ingelheim Ingelvac PRRSmLV Swine Vaccine 500 mL/250 Dose

Ingelvac PRRS® MLV, a leading modified-live PRRS vaccine, has been trusted for over 20 years to protect the swine industry against respiratory and reproductive symptoms of PRRSv.

Ingelvac PRRS® MLV is a modified-live PRRS vaccine that is proven safe in pigs as well as gilts and sows at any stage of production in PRRS positive herds. It provides cross protection against heterologous challenge; (including Lelystad virus) and has shown to significantly reduce reproductive failure and respiratory disease due to PRRS virus.

Features

• Safe in pigs, gilts and sows at any stage of production.
• Aids in the prevention of respiratory disease and aids in the reduction of reproductive disease caused by PRRS virus.
• Proven cross protection against heterologous challenge; (including Lelystad virus).
• Easy to use, cost effective and field proven against respiratory and reproductive forms of PRRS Virus.
• Convenience of 10, 50 and 250 dose presentations.

Benefits

• Long-lasting immunity. Duration of immunity is at least 4 months.
• Whole herd or population based PRRS control program advantages.
• Significantly reduces reproductive failure due to PRRS virus.
• Gilt stabilization/acclimatization program advantages.

• Whole herd or population based PRRS control programs.
• Replacement gilt immunizationand preparation.
• Reproductive maintenance vaccination program in sows.
• Administration in growing pigs to aid in prevention of respiratory disease